Glomerular Disease Pathogenesis: What's New?
October 24, 2020 | 02:30 PM - 04:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Basic/Clinical Science Session
Glomerular Disease Pathogenesis: What's New?
October 24, 2020 | 02:30 PM - 04:30 PM
Location: Simulive
Session Description
Taken together, primary and secondary glomerular diseases account for 90% of all ESKD in the United States, at a cost in excess of $20 billion per year. The development of novel therapeutics is limited by poor understanding of the underlying disease pathogenesis. This session highlights novel and emerging concepts driving the understanding of cellular injury, degeneration, and cross-talk that could help advance the quest for better treatment options.
Learning Objective(s)
- Identify glomerular metabolic changes in hypertensive nephropathy
- Define mechanisms underlying pathogenic endothelial-podocyte cross-talk
- Discuss the contribution of lipids to glomerular disease progression
- Describe the pathogenesis of immune-mediated podocyte injury
Learning Pathway(s)
- Glomerular Diseases
- Pathology
Moderators
- Kyung Lee, PhD
- Joshua M. Thurman, MD
Presentations
- Glomerular Metabolic Changes in Hypertensive Kidney Disease
02:30 PM - 03:00 PM
Markus M. Rinschen, MD
Glomerular Metabolic Changes in Hypertensive Kidney Disease
October 24, 2020 | 02:30 PM - 03:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Mechanism of Pathogenic Podocyte-Endothelial Cross-Talk
03:00 PM - 03:30 PM
Ilse S. Daehn, PhD, FASN
Ilse S. Daehn, PhD, FASN
My research focuses on exploring the complexity of signaling crosstalk between cells in the kidney. The major research interest is to understand the impact of redox processes and molecular mechanisms in the glomerulus that result in kidney disease progression in order to identify novel glomerular lesion-specific therapeutic targets and biomarkers. In particular we are examining the signaling crosstalk between podocytes, endocapillary cells and mesangial cells that lead to irreversible segmental sclerosis characteristic of glomerular disease progression.
Mechanism of Pathogenic Podocyte-Endothelial Cross-Talk
October 24, 2020 | 03:00 PM - 03:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Immune-Mediated Podocyte Injury: Pathogenesis and Therapeutic Opportunities
03:30 PM - 04:00 PM
Eunsil Hahm, PhD
Immune-Mediated Podocyte Injury: Pathogenesis and Therapeutic Opportunities
October 24, 2020 | 03:30 PM - 04:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Lipids in Cellular Injury and Glomerular Disease
04:00 PM - 04:30 PM
Sandra M. Merscher, PhD
Sandra M. Merscher, PhD
Dr. Merscher is a Research Associate Professor at the University of Miami – Miller School of Medicine, Miami, FL. Research in Dr. Merscher’s laboratory focuses on elucidating and understanding the molecular mechanisms that contribute to the development of proteinuria in glomerular diseases with an emphasis on lipotoxicity-induced podocyte injury. Dr. Merscher has co-authored more than 35 peer-reviewed journal articles, she is scientific reviewer for several peer-reviewed scientific journals, review editorial board member for Frontiers in Medicine (Nephrology), and has served as a grant reviewer for the American Heart Association since 2012. Research in Dr. Merscher’s laboratory is supported by several NIH- and industry-sponsored grants.
Lipids in Cellular Injury and Glomerular Disease
October 24, 2020 | 04:00 PM - 04:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
